U.S. Luxury Stock News

In August 2026, AppFolio, Inc. announced it had named Amazon Web Services as its preferred cloud provider, with its AI-native Performance Platform and Realm suite of AI capabilities running on AWS infrastructure such as Amazon MSK and Amazon Bedrock. This deep collaboration gives AppFolio access to leading foundation models and governance tools while allowing it to refine AWS services to its performance standards, strengthening the technical backbone behind its real estate SaaS...

Route cuts, premium focus and AI tools put Delta Air Lines stock in the spotlight Delta Air Lines (DAL) is reshaping its network by cutting lower margin, price sensitive routes, expanding Premium Select cabins and rolling out AI driven pricing and operational tools that aim to sharpen profitability and efficiency. See our latest analysis for Delta Air Lines. At a share price of $82.41, Delta Air Lines has seen short term pressure, with the 7 day share price return down 7.77% and the 30 day...

MetroCity Bankshares (MCBS) drew fresh attention after announcing that vice chairman Don T.P. Leung will resign from the board and multiple key committees in September. The move is raising questions about board structure and risk oversight. See our latest analysis for MetroCity Bankshares. Set against this governance change, MetroCity Bankshares’ recent share price return has cooled over the past month compared with earlier strength, even though the 90 day share price return of 9.12% and 3...

Nomad Foods Limited has released its second-quarter and half-year 2026 results, reporting sales of €723.7 million and €1.44 billion respectively, with lower net income and earnings per share than the same periods a year earlier. The simultaneous decline in both sales and profitability across the quarter and first half of 2026 highlights pressure on Nomad Foods’ operational performance and cost management. Next, we will examine how this softer revenue and earnings performance shapes Nomad...

Why Pelagos Insurance Capital Stock Is Back on Investors’ Radar Pelagos Insurance Capital (PLGO) drew fresh attention after reporting second quarter and first half 2026 results that showed higher revenue, a swing to net profit and continued execution on its share repurchase program. See our latest analysis for Pelagos Insurance Capital. Pelagos Insurance Capital’s earnings rebound and ongoing buybacks have come alongside a 24.05% year to date share price return and a 41.39% total shareholder...

Victory Capital Holdings stock update Victory Capital Holdings (VCTR) drew fresh attention after its recent share price move, with the stock closing at $115.63. Investors are weighing this level against the company’s latest financial profile and recent return history. See our latest analysis for Victory Capital Holdings. The recent move to a US$115.63 share price comes after a strong run, with an 18.96% 1 month share price return and an 80.39% year to date share price return, alongside a 5...

Marex Group Limited recently reported half-year 2026 results showing net income of US$268 million and significantly higher earnings per share versus a year earlier, while also affirming a quarterly dividend of US$0.16 per share payable on September 9, 2026. Alongside stronger profitability, Marex’s decision to maintain its regular cash dividend sends a clear signal about management’s confidence in the company’s financial position and cash-generation capacity. We’ll now examine how Marex’s...

TransDigm Group stock performance snapshot TransDigm Group (TDG) has drawn investor attention after a mixed share price pattern. The stock is up about 1.7% today, yet it is down over the past week, month, and past 3 months. Year to date, TransDigm Group has declined about 11.6%, with the 1 year total return down roughly 8.9%. Longer term holders have seen higher total returns over 3 and 5 years, based on the data provided. The company last closed at US$1,200.35, giving TransDigm Group an...

In August 2026, Spyre Therapeutics announced SPY772, a new preclinical combination program pairing its long-acting anti-TL1A antibody SPY072 with the novel long-acting anti-IL-17A/F antibody SPY007, and reported the start of SKYLIGHT, a randomized, placebo-controlled Phase 2 proof-of-concept trial in approximately 150 adults with moderate-to-severe Hidradenitis Suppurativa receiving background bimekizumab therapy, with topline data planned for late 2027 or early 2028. This dual-inhibition...

Hyatt Hotels Corporation and RJR Investments & Holdings Inc. recently added Atlantic Suites Hotel in Georgetown, Guyana to the Hyatt portfolio as its first affiliated property in the country, with plans for an approximately US$50 million expansion that will convert it into Hyatt Regency Georgetown Guyana by 2028. This move extends Hyatt’s reach into an emerging Latin America and Caribbean market while deepening the World of Hyatt ecosystem through future loyalty integration and a planned...

Celcuity (CELC) reported second quarter 2026 results that showed a wider net loss, an update that can influence how investors evaluate the stock’s risk profile and long term development plans. See our latest analysis for Celcuity. Celcuity’s latest earnings report, which showed a larger net loss, arrived as the stock posted a 1 month share price return of 13.21% but a 3 month share price decline of 32.34%. The 1 year total shareholder return of 78.42% highlights how longer term momentum has...

Earlier this month, Herbalife reported quarterly revenues of US$1.33 billion, up 5.4% year on year and 1.5% above analyst expectations, but significantly missed earnings-per-share estimates and issued relatively weak forward guidance. This combination of stronger sales but softer profitability and outlook highlights an ongoing tension between Herbalife’s top-line momentum and its ability to convert that into earnings growth. We’ll now examine how Herbalife’s revenue beat but weak guidance...

Zscaler (ZS) is back in focus after it expanded its partnership with Carahsoft to push its Zero Trust Exchange deeper into U.S. small and mid-sized businesses, a move that intersects with stronger interest in SASE leaders. See our latest analysis for Zscaler. The partnership news lands after a mixed run for Zscaler, with the share price gaining 27.7% over the last 30 days but the year to date share price return declining 17.6%. Over the last year, the total shareholder return is down 33.31%,...

Biohaven earnings update and what it means for investors Biohaven (BHVN) reported second quarter 2026 results that showed a reduced net loss of US$137.31 million. Loss per share from continuing operations was US$0.91, compared with US$1.94 a year earlier. For the first half of 2026, Biohaven reported a net loss of US$267.84 million, with basic loss per share from continuing operations of US$1.80, compared with US$4.11 in the prior year period. See our latest analysis for Biohaven. Biohaven’s...

In August 2026, QIAGEN announced that the U.S. FDA had cleared its QIAstat-Dx BCID GPF Plus AMR Panel, the first QIAstat-Dx bloodstream infection panel to receive FDA clearance, expanding the platform’s U.S. coverage to four infectious disease areas and delivering one-hour pathogen and resistance marker results from positive blood cultures. This clearance not only broadens QIAGEN’s infectious disease testing menu on a single integrated platform, but also positions the company to address the...

Alphabet (NasdaqGS:GOOGL) subsidiary Waymo has developed a custom AI chip for its robotaxis, aimed at improving on-vehicle processing of sensor data and neural network workloads. The application specific integrated circuit is designed for tighter integration between Waymo's software stack and in-house hardware. The move reduces Waymo's reliance on third party chip suppliers and fits within Alphabet's broader push to manage AI computing infrastructure costs internally. Readers looking to...

Credit Acceptance (CACC) has drawn investor attention after completing a US$600 million asset backed non recourse secured financing and naming former Amazon executive Jeetu Mirchandani as Chief Technology Officer earlier this month. See our latest analysis for Credit Acceptance. These financing and leadership moves have come alongside a steady build in momentum for Credit Acceptance, with a 32.41% year to date share price return and a 1 year total shareholder return of 18.67% pointing to...

In the past quarter, Reliance reported strong Q2 2026 results, with adjusted earnings per share rising very large on the back of higher shipments, firmer pricing, and contributions from a U.S. border wall project, while management highlighted healthy demand across non-residential construction, aerospace, automotive, and semiconductor markets. An interesting angle is how the border wall project and improved gross profit per ton show Reliance monetising complex, project-based work alongside...

Interactive Brokers Group (IBKR) has just broadened its reach through two client focused moves. A new SafetyPay funding option targets Latin American investors, and fresh access to the Bucharest Stock Exchange widens global trading choices. See our latest analysis for Interactive Brokers Group. These client focused initiatives have arrived during a strong run in Interactive Brokers Group’s stock, with a year to date share price return of 39.63% and a 1 year total shareholder return of 51.12%,...

McGrath RentCorp (MGRC) is back in focus for investors after recent share price swings, with the stock last closing at $116.65. The move is prompting closer attention to its rental-focused business model. See our latest analysis for McGrath RentCorp. Recent trading in McGrath RentCorp has been choppy, with a 7 day share price return of down 4.6% and a 30 day share price return of down 2.6%. However, the year to date share price return of 10.85% and a 5 year total shareholder return of 82.79%...

Candel Therapeutics (CADL) is back in focus after reporting second quarter 2026 results that showed a net loss of US$38.91 million. This compared with net income for the first half of 2025. See our latest analysis for Candel Therapeutics. The earnings release has come alongside strong momentum in Candel Therapeutics' stock, with a 1 month share price return of 37.34% and a year to date share price return of 141.36%. The 3 year total shareholder return is very large at around 9x, suggesting...

Recent performance puts Eastman Chemical in focus Eastman Chemical (EMN) has moved onto investor watchlists after a recent share price run that left the stock up about 9% over the past month and roughly 15% year to date. See our latest analysis for Eastman Chemical. The recent 30 day share price return of 8.64% has helped Eastman Chemical regain some momentum after a flat 90 day move, even though the 5 year total shareholder return of 22.54% below zero shows a weaker longer term picture. If...

Housing affordability pressures and recent News stock moves Recent housing data showing a sizeable drop in online buyer interest for homes below $370,000 has drawn attention to News (NWSA) and its exposure to digital real estate and media businesses. The stock has delivered mixed share price performance, with a gain of about 8% over the past month following a stronger multi year run. This keeps valuation and housing related trends in focus for investors. See our latest analysis for News. Over...

Earlier this week, Hyperliquid Strategies drew fresh attention after Donald Trump said CFTC Chair Mike Selig is working on a compliant legal route for the Hyperliquid exchange to operate in the U.S., spotlighting potential regulatory clarity for the platform. This shift toward a possible U.S.-compliant framework has sharpened the focus on how much of Hyperliquid Strategies’ appeal rests on regulatory momentum rather than established financial fundamentals. We’ll now examine how the prospect...